Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert T Jacobs

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Organic Process Research & Development|February 3, 2022
A New Scalable Synthesis of ELQ-300, ELQ-316, and other Antiparasitic QuinolonesSovitj Pou, Rozalia A Dodean, Lisa Frueh, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery and structure-activity relationships of 6-(benzoylamino)benzoxaboroles as orally active anti-inflammatory agentsTsutomu Akama, Chen Dong, Charlotte Virtucio, et al.
Journal of Medicinal Chemistry|June 22, 2017
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical CandidateYong-Kang Zhang, Jacob J Plattner, Eric E Easom, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma bruceiJoe B Perales, Jennifer Freeman, Cyrus J Bacchi, et al.
Journal of Medicinal Chemistry|June 13, 2015
Benzoxaborole antimalarial agents. Part 4. Discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaborolesYong-Kang Zhang, Jacob J Plattner, Eric E Easom, et al.
Future Medicinal Chemistry|August 24, 2011
Benzoxaboroles: a new class of potential drugs for human African trypanosomiasisRobert T Jacobs, Jacob J Plattner, Bakela Nare, et al.
Bioorganic & Medicinal Chemistry Letters|November 25, 2017
Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT)Tsutomu Akama, Yong-Kang Zhang, Yvonne R Freund, et al.
Plos Pathogens|February 10, 2018
Host-parasite co-metabolic activation of antitrypanosomal aminomethyl-benzoxaborolesNing Zhang, Martin Zoltner, Ka-Fai Leung, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of novel benzoxaborole-based potent antitrypanosomal agentsDazhong Ding, Yaxue Zhao, Qingqing Meng, et al.
Nature Communications|June 29, 2019
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosisChristopher S Lunde, Erin E Stebbins, Rajiv S Jumani, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Organic Process Research & Development|February 3, 2022
A New Scalable Synthesis of ELQ-300, ELQ-316, and other Antiparasitic QuinolonesSovitj Pou, Rozalia A Dodean, Lisa Frueh, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery and structure-activity relationships of 6-(benzoylamino)benzoxaboroles as orally active anti-inflammatory agentsTsutomu Akama, Chen Dong, Charlotte Virtucio, et al.
Journal of Medicinal Chemistry|June 22, 2017
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical CandidateYong-Kang Zhang, Jacob J Plattner, Eric E Easom, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma bruceiJoe B Perales, Jennifer Freeman, Cyrus J Bacchi, et al.
Journal of Medicinal Chemistry|June 13, 2015
Benzoxaborole antimalarial agents. Part 4. Discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaborolesYong-Kang Zhang, Jacob J Plattner, Eric E Easom, et al.
Future Medicinal Chemistry|August 24, 2011
Benzoxaboroles: a new class of potential drugs for human African trypanosomiasisRobert T Jacobs, Jacob J Plattner, Bakela Nare, et al.
Bioorganic & Medicinal Chemistry Letters|November 25, 2017
Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT)Tsutomu Akama, Yong-Kang Zhang, Yvonne R Freund, et al.
Plos Pathogens|February 10, 2018
Host-parasite co-metabolic activation of antitrypanosomal aminomethyl-benzoxaborolesNing Zhang, Martin Zoltner, Ka-Fai Leung, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of novel benzoxaborole-based potent antitrypanosomal agentsDazhong Ding, Yaxue Zhao, Qingqing Meng, et al.
Nature Communications|June 29, 2019
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosisChristopher S Lunde, Erin E Stebbins, Rajiv S Jumani, et al.
Pageof 3